Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Becophos-L
- Development stage
- Unknown
- Lead developer
- TCF Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Becophos-L is an oral nutritional supplement syrup developed and marketed by TCF Pharmaceuticals. It is formulated as a combination of Vitamin B-complex and L-lysine, primarily indicated for the prevention and treatment of nutritional deficiencies. Vitamin B-complex serves as a crucial cofactor in various enzymatic reactions and metabolic processes, while L-lysine is an essential amino acid that supports protein synthesis, growth, and immune function. Together, these components help address dietary gaps, support energy metabolism, and promote overall health.
- Brand names
- Becophos-L
- Other names
- Vitamin B complex + L-lysineVitamin B-complex + L-lysine
Beyond the preview
Go deeper on Becophos-L.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Becophos-L.